Poly Medicure Ltd (POLYMED) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531768 | NSE: POLYMED | Medical Equipment/Supplies/Accessories | Small Cap

Poly Medicure Share Price

1,893.80 -9.75 -0.51%
as on 05-Dec'25 14:30

Poly Medicure Ltd (POLYMED) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531768 | NSE: POLYMED | Medical Equipment/Supplies/Accessories | Small Cap

DeciZen - make an informed investing decision on Poly Medicure

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Poly Medicure stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
55.32
Market Cap:
19,294.3 Cr.
52-wk low:
1,822.7
52-wk high:
3,031.5

Is Poly Medicure Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Poly Medicure: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Poly Medicure Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 26.1%25.3%26%22.9%24.6%21.6%17.7%19.3%23.3%20.1%-
Value Creation
Index
0.90.80.90.60.80.60.30.40.70.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3944405085876467478791,0681,3071,6021,632
Sales YoY Gr.-11.4%15.7%15.4%10.1%15.7%17.7%21.5%22.4%22.5%-
Adj EPS 55.67.16.99.612.914.317.92531.234.4
YoY Gr.-12.4%27.1%-3.1%39.4%34%10.7%25.6%39.6%24.6%-
BVPS (₹) 25.430.537.94348.699.4112.1128.4151.6270.6285
Adj Net
Profit
4449.562.960.985124137172240316349
Cash Flow from Ops. 61.95575.5113127116126197256237-
Debt/CF from Ops. 1.31.81.71.31.51.10.90.70.60.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 16.9%19.9%22.1%22.5%
Adj EPS 22.6%26.5%29.8%24.6%
BVPS30.1%41%34.1%78.5%
Share Price 27.8% 30.8% 25.4% -35.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
21.220.120.817.12117.913.514.917.81512.4
Op. Profit
Mgn %
21.921.423.922.825.128.224.325.326.927.927.2
Net Profit
Mgn %
11.211.312.410.413.216.515.616.118.419.721.4
Debt to
Equity
0.40.40.40.40.40.10.10.10.10.10
Working Cap
Days
144146157159173182177173167165198
Cash Conv.
Cycle
67758080787889928793156

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Poly Medicure Ltd.

Standalone Consolidated
TTM EPS (₹) 34.4 35.7
TTM Sales (₹ Cr.) 1,632 1,712
BVPS (₹.) 285 287.9
Reserves (₹ Cr.) 2,838 2,868
P/BV 6.68 6.61
PE 55.32 53.30
From the Market
52 Week Low / High (₹) 1822.65 / 3031.50
All Time Low / High (₹) 0.50 / 3350.00
Market Cap (₹ Cr.) 19,294
Equity (₹ Cr.) 50.7
Face Value (₹) 5
Industry PE 53.3

Management X-Ray of Poly Medicure:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Poly Medicure - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Poly Medicure

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales3944395085876467478791,0681,3071,602
Operating Expenses 3083453874534845376658029561,154
Manufacturing Costs100113131143153162200243276337
Material Costs107110121152153197261300364424
Employee Cost 698194110127131150188229280
Other Costs 334141485147547088113
Operating Profit 8694122134162210214266351447
Operating Profit Margin (%) 21.9%21.4%23.9%22.8%25.1%28.1%24.3%24.9%26.9%27.9%
Other Income 8141416191939365890
Interest 108111320105101314
Depreciation 20232836394653566281
Exceptional Items 0000000000
Profit Before Tax 657696100122173195237335443
Tax 182026342944495883112
Profit After Tax 4756706692130146179252331
PAT Margin (%) 12.0%12.8%13.8%11.3%14.3%17.3%16.6%16.8%19.3%20.7%
Adjusted EPS (₹)5.46.48.07.510.513.515.218.726.232.7
Dividend Payout Ratio (%)28%39%25%27%19%19%16%16%11%11%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 2242693343794299531,0751,2321,4552,742
Share Capital 22444444444848484851
Reserves 2022252903353859051,0271,1841,4072,691
Minority Interest0000000000
Debt61761061271559181112146167
Long Term Debt3148799111160311210
Short Term Debt30282735443150101145167
Trade Payables30414350605678788977
Others Liabilities 616371105128131100173204242
Total Liabilities 3764495556617721,2311,3341,5961,8943,228

Fixed Assets

Gross Block2883334174615506557649631,2551,536
Accumulated Depreciation111133161192226270317365424489
Net Fixed Assets 1772002562693243854475978311,047
CWIP 14201819252143787193
Investments 661846583853841812211,127
Inventories41586974101109150183193250
Trade Receivables8195112124120149191221259340
Cash Equivalents 2122205322278171137143
Others Assets 37476176122154110165183227
Total Assets 3764495556617721,2311,3341,5961,8943,228

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 625575113127116126197256237
PBT 657696100122173195237335443
Adjustment 25223841504539603636
Changes in Working Capital -14-25-36-1-10-58-60-42-41-154
Tax Paid -14-18-23-27-36-44-47-58-74-89
Cash Flow From Investing Activity -30-54-87-104-106-434-89-189-237-1,191
Capex -31-55-81-45-104-93-150-237-269-324
Net Investments -1-2-8-62-7-344574820-882
Others 232353401215
Cash Flow From Financing Activity -31-114-10-22319-40-8-17953
Net Proceeds from Shares 000004000001,000
Net Proceeds from Borrowing 0000000000
Interest Paid -8-7-9-12-9-8-4-8-10-11
Dividend Paid -27-13-5-21-420-24-24-29-30
Others 419292330-73-122422-6
Net Cash Flow 103-1-11-2-02-2

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)22.7522.8123.2818.5822.8518.7414.415.5218.7415.79
ROCE (%)26.1425.325.9622.9224.6421.6217.6819.3423.2820.14
Asset Turnover Ratio1.11.081.020.970.910.750.690.730.750.63
PAT to CFO Conversion(x)1.320.981.071.711.380.890.861.11.020.72
Working Capital Days
Receivable Days64727473696570706768
Inventory Days43404544495154575250
Payable Days11611712711213110894958471

Poly Medicure Ltd Stock News

Poly Medicure Ltd FAQs

The current trading price of Poly Medicure on 05-Dec-2025 14:30 is ₹1,893.8.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Poly Medicure stood at ₹19,294.3.
The latest P/E ratio of Poly Medicure as of 04-Dec-2025 is 55.32.
The latest P/B ratio of Poly Medicure as of 04-Dec-2025 is 6.68.
The 52-week high of Poly Medicure is ₹3,031.5 and the 52-week low is ₹1,822.7.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Poly Medicure is ₹1,632 ( Cr.) .

About Poly Medicure Ltd

Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products.

POLYMED manufactures its products using state of the art technology in ultra modern facilities covering over 300,000 square feet of manufacturing floor space with about 50,000 square feet of clean rooms of class 100,000 to class 1,000. A tool room with modern facilities & CNC machines supports the manufacturing processes. A high degree of automation and an effective process control helps in delivering consistent product quality.

To keep pace with the ever changing requirements of the market, POLYMED has a fully staffed and highly equipped R & D section to design and develop new and innovative products. Using the latest CAD/CAM technology, the new product development is fast and improvements, based on market response and customer feedback, are made with ease. Assuring world class products at affordable prices is the hall mark of POLYMED

Product range of the company:

The company manufactures different products related to :

  • Infusion Therapy
  • Central Venous Access Catheters
  • Anaesthesia
  • Urology
  • Gastroenterology
  • Blood Management
  • Surgery & Wound Drainage
  • Dialysis
  • Others

Achievements/ recognition:

  • QMS (Quality Management System) accredited by SGS
  • ISO 9001:2000
  • ISO-13485:2003
  • CE mark from DNV
  • US FDA 510k approved  
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×